Drug Resistance in Falciparum Patients Treated with Mefloquine-sulphadoxine-pyrimethanine in Myanmar

ABSTRACT

3 out of 32 P. falciparum malaria patients treated with Mefloquine-Sulfadoxig-Pyrimethamine combinations at Tharrawaddy Township Hospital, Myanmar failed to respond to the drug. One of the patients was regarded as R2 and another two as R1 resistance to the drug. One of them was also resistance to Mefloquine and Quinine in in-vitro studies. We conclude that there are patients who failed to respond to Mefloquine-Sulfadoine-Pyrime-thamine even in areas where Mefloquine had never been used.